
Inlybest 1mg Tablet
Marketer
Aprazer Healthcare Pvt Ltd
Salt Composition
Axitinib (1mg)
Overview Inlybest 1mg Tablet
Renal cancer patients may be prescribed Inlybest 1mg tablets, an anti-neoplastic medication. Administration may occur with or without food, but consistent daily timing optimizes therapeutic effects. Dosage and frequency are determined by your physician, contingent on your specific condition and subject to adjustment. Adhere strictly to your doctor's instructions; improper usage or overdose can lead to severe adverse reactions. While benefits might not be immediately apparent (weeks or months may pass), discontinue use only under your doctor's guidance. Common side effects encompass hypertension, arthralgia, and anorexia. Diarrhea and dyspnea, potentially serious, require prompt medical attention, including hydration and prescribed medication. Regular blood pressure monitoring is often recommended. Report severe headaches, cognitive impairment, visual disturbances, nausea, or vomiting to your physician. Prior to initiating treatment, disclose any thyroid disorders, hepatic issues, bleeding disorders, or concurrent use of antimicrobial agents. Numerous drug interactions are possible; therefore, inform your healthcare provider of all medications. This medication is contraindicated during pregnancy and lactation. Women of childbearing potential should utilize effective contraception throughout treatment to prevent pregnancy.
Uses of Inlybest 1mg Tablet
Renal cell carcinoma
Major Benefits of Inlybest 1mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Inlybest 1mg Tablets. Swallow the tablet whole; do not crush, chew, or break it. While Inlybest 1mg may be administered with or without food, consistent daily timing is recommended.
Common Side effects of Inlybest 1mg Tablet:
- High blood pressure
- Joint pain
- Loss of appetite
- Diarrhea
- Breathing problems
- Abdominal pain
- Constipation
- Cough
- Decreased appetite
- Decreased level of thyroid hormones
- Difficulty in speaking
- Dry skin
- Indigestion
- Headache
- Nausea
- Pain in extremities
- Painful blisters on hands and feet
- Protein in urine
- Rash
- Breathlessness
- Stomatitis (Inflammation of the mouth)
- Taste change
- Vomiting
How to use Inlybest 1mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Inlybest 1mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Inlybest 1mg Tablet works:
Oncaspare 1mg tablets are a cancer treatment that inhibits the activity of a mutated protein responsible for cancer cell proliferation, thereby curbing or slowing cancerous growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Inlybest 1mg Tablet may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Pregnant individuals should not take Inlybest 1mg Tablets due to confirmed risks to the fetus. Exceptions may exist in critical situations where a physician deems the potential benefits outweigh the hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Inlybest 1mg Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Inlybest 1mg Tablet may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Inlybest 1mg tablets pose no safety concerns for individuals with kidney impairment; dosage modification is unnecessary.
LiverCAUTION
Patients with liver impairment should use Inlybest 1mg Tablet cautiously, potentially requiring dosage modification. Consult a physician for guidance. Data on Inlybest 1mg Tablet use in individuals with severe hepatic dysfunction is limited.
What if you forget to take Inlybest 1mg Tablet :
NA
Facts to Know About Inlybest 1mg Tablet
| Label | Value |
|---|---|
| Pharmaceutical Category | Enzamide-based medication and an indazole derivative compound. |
| Potential for Dependence | None. |
| Type of Treatment | Cancer-fighting drugs |
| Mechanism of Action | Kinase inhibitors targeting tyrosine |
